xmlui.ArtifactBrowser.ItemViewer.show_simple

dc.contributor.authorBensabath, Gilberta-
dc.contributor.authorHadler, Stephen C-
dc.contributor.authorSoares, Manoel do Carmo Pereira-
dc.contributor.authorFields, Howard-
dc.contributor.authorDias, Leônidas B-
dc.contributor.authorPopper, Hans-
dc.contributor.authorMaynard, James E-
dc.date.accessioned2017-09-12T10:13:28Z-
dc.date.available2017-09-12T10:13:28Z-
dc.date.issued1987-
dc.identifier.citationBENSABATH, Gilberta et al. Hepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basin. JAMA, v. 258, n. 4, p. 24-31, July 1987.pt_BR
dc.identifier.issn0098-7484-
dc.identifier.urihttp://patua.iec.gov.br//handle/iec/2728-
dc.description.abstractTo define more exactly the epidemiology of delta virus infection and confirm its role in causing fulminant Labrea hepatitis in the Amazon Basin, we studied the prevalence of delta virus infection among persons with acute and chronic hepatitis B virus infection in the Boca do Acre district of the southern Amazon Basin. Delta virus infection was found in 24% of asymptomatic hepatitis B virus carriers, 29% of acute nonfulminant hepatitis B cases, 74% of fulminant hepatitis B cases, and 100% of chronic hepatitis B cases. Chronic delta virus infection occurred primarily in older children and adults, while acute and fulminant delta virus infection occurred in young children as well. In fulminant hepatitis cases, delta virus superinfection of hepatitis B virus carriers was the most common serological pattern; histopathologic examination showed features identical to those described in fulminant hepatitis cases of similar etiology in Colombia and Venezuela. Delta virus infection is highly endemic in the southern Amazon Basin and is the principal cause of Labrea hepatitis.pt_BR
dc.language.isoengpt_BR
dc.publisherAmerican Medical Associationpt_BR
dc.rightsAcesso Embargadopt_BR
dc.titleHepatitis delta virus infection and Labrea hepatitis. Prevalence and role in fulminant hepatitis in the Amazon Basinpt_BR
dc.typeArtigopt_BR
dc.subject.decsPrimaryVírus Delta da Hepatite / solamento & purificaçãopt_BR
dc.subject.decsPrimaryHepatite / diagnósticopt_BR
dc.subject.decsPrimaryHepatite B / complicaçõespt_BR
dc.subject.decsPrimaryHepatite B / epidemiologiapt_BR
dc.subject.decsPrimaryHepatite D / complicaçõespt_BR
dc.subject.decsPrimaryHepatite D / epidemiologiapt_BR
dc.subject.decsPrimaryBacia Amazônica do Sul (AC)pt_BR
dc.subject.decsPrimaryBoca do Acre (AC)pt_BR
dc.creator.affilliationMinistério da Saúde. Fundação Serviços de Saúde Pública. Instituto Evandro Chagas. Belém, PA, Brasil.pt_BR
dc.creator.affilliationCenters for Disease Control. Division of Viral Diseases. The Hepatitis Branch. Atlanta, GA, EUA.pt_BR
dc.creator.affilliationMinistério da Saúde. Fundação Serviços de Saúde Pública. Instituto Evandro Chagas. Belém, PA, Brasil.pt_BR
dc.creator.affilliationCenters for Disease Control. Division of Viral Diseases. The Hepatitis Branch. Atlanta, GA, EUA.pt_BR
dc.creator.affilliationMinistério da Saúde. Fundação Serviços de Saúde Pública. Instituto Evandro Chagas. Belém, PA, Brasil.pt_BR
dc.creator.affilliationCity University of New York. Mount Sinai School of Medicine. The Stratton Laboratory for Study of Liver Diseases. New York, NY, EUA.pt_BR
dc.creator.affilliationCenters for Disease Control. Division of Viral Diseases. The Hepatitis Branch. Atlanta, GA, EUA.pt_BR


xmlui.dri2xhtml.METS-1.0.item-files-head

Thumbnail

xmlui.ArtifactBrowser.ItemViewer.head_parent_collections

xmlui.ArtifactBrowser.ItemViewer.show_simple